Owing to their unique immunomodulatory properties, mesenchymal stem cells (MSCs) have
been advocated as a potential therapy for numerous pathological conditions in which
immune-mediated inflammatory reactions play a crucial role, such as autoimmune disorders,
cerebrovascular diseases and tumours. Increasing evidence suggest that stem cells, other
than MSCs, are also capable of immunomodulation. Neural stem/precursor cells (NPCs)
have been among the first stem cells to show immunomodulatory properties and nowadays …